Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Evome Medical Technologies Inc LNDZF


Primary Symbol: V.EVMT

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers... see more

TSXV:EVMT - Post Discussion

View:
Post by Inobambino on Aug 14, 2024 7:05pm

Evome/Biodex

So am I correct in understanding that the company made several acquisitions over the past few years, all of which were unprofitable with the exception of Biodex ? This is leading to them divesting these acquisitions and just focusing on Biodex, or are there still aspects of the original buisness plan that have value for Evome ?
I bought in following an extremely strong recommendation(s) from Bruce Campbell on BNN and have watched my investment lose money month after month for several years now. I really hope they are on the right track now. It sounds like they have somehting good with Biodex, which is a massive relief, but is Biodex all they have going for them ?

If anyone has any two cents I would love to hear it :)

Cheers.
Comment by taylorsimms86 on Aug 14, 2024 7:41pm
Correct, Biodex was always the main business and lots of runway for growth and white labeling products to sell in the distribution chain...was a different market 3 years ago and the new CEO has come in to clean up what the old management did...some of these companies make money like Damar but they have too much debt so Mike has laid out a plan to sell these non core  assets and pay off all ...more  
Comment by taylorsimms86 on Aug 14, 2024 7:45pm
Also everyone has to stop blaming Bruce Campbell for their own mistakes...he runs a fund and if you want not only his best ideas but also his exits then invest in his fund. The guy had a 10 year track record of top decile performance. Managers don't make public when they exit and they also have a portfolio strategy where some willl win and some names will lose but the overall portfolio returns ...more  
Comment by jer13leafs on Aug 15, 2024 9:49am
Looks like it took only 12 hours to get your answer. LOL It seems like they are trying to accelerate growth for overall value and limit costs. I hope it translates to the stock price movement. Good Luck, All the best I do like this Quote: “From a financial perspective, our plan is based on using very limited capital thereby reducing our need for debt or equity financing to grow revenue,” he ...more  
Comment by Inobambino on Aug 15, 2024 2:30pm
Yes, good timing ! It sounds like they feel really good about Biodex and the opportunities to grow that business. It's nice to have some optimisim again !
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities